233063
232902

Kelowna  

Patients sought for drug trial

People with memory impairment or early Alzheimer’s disease are invited to participate in an investigational medication study.

Okanagan Clinical Trials is conducting the study to determine the medication's effectiveness. 

“Memory impairment and Alzheimer’s disease are devastating conditions with very few viable treatment options,” said Dr. Paul Latimer, psychiatrist and principal investigator for Okanagan Clinical Trials. “With an aging population and numbers on the rise, it is very important to continue searching for safe and effective treatments.”

Alzheimer’s is the most common form of dementia and affects almost 39 million people worldwide. Typically, it begins by affecting an individual’s short-term memory. 

Eligible volunteers for the study should be between the ages of 50 and 85.

More than 750 participants are being sought. 

Effects of the study medication will be measured over two years, with the possibility of an open-label extension study. Participation will not affect provincial medical coverage, and all study-related costs will be paid for by the sponsor. Participants are free to leave the study at any time.

Okanagan Clinical Trials can be reached at 250-862-8141.



More Kelowna News